These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19525613)

  • 1. "Aseptic pneumonitis".
    Koga T
    Intern Med; 2009; 48(12):1115-6. PubMed ID: 19525613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cefepime in the treatment of hospital-acquired pneumonia].
    Iakovlev SV; Romashov OM; Protsenko DN
    Antibiot Khimioter; 2003; 48(7):38-43. PubMed ID: 14628578
    [No Abstract]   [Full Text] [Related]  

  • 3. Could geriatric comprehensive assessment predict the outcome of pneumonia in the very old?
    Pepersack T; de Breucker S
    Age Ageing; 2007 Jul; 36(4):455-9. PubMed ID: 17636270
    [No Abstract]   [Full Text] [Related]  

  • 4. Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia.
    To KK; Chan KH; Fung YF; Yuen KY; Ho PL
    Eur Respir J; 2010 Oct; 36(4):969-71. PubMed ID: 20889469
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized trial of cefepime (BMY-28142) and ceftazidime for the treatment of pneumonia.
    Edelstein H; Chirurgi V; Oster S; Karp R; Cassano K; Aiken S; McCabe R
    J Antimicrob Chemother; 1991 Oct; 28(4):569-75. PubMed ID: 1761451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An 87-Year-Old Man with Acute Catastrophic Pneumonia.
    Mohamed AM; Waheed SA; Mohamed NM; Clark NM
    Ann Am Thorac Soc; 2016 Mar; 13(3):432-7. PubMed ID: 26963355
    [No Abstract]   [Full Text] [Related]  

  • 7. Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia.
    Aitken SL; Altshuler J; Guervil DJ; Hirsch EB; Ostrosky-Zeichner LL; Ericsson CD; Tam VH
    Int J Antimicrob Agents; 2015 May; 45(5):541-4. PubMed ID: 25665726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of cefepime and ceftazidime for the treatment of community-acquired pneumonia.
    Bonfitto P; Lamorgese V; De Vietro T; Malerba M; Rizzello L; Scoditti S; Zuin R
    J Chemother; 1999 Aug; 11(4):273-7. PubMed ID: 10465129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A 17-year-old student with therapy-resistant pneumonia].
    Rauch N; Ullmer E; Matt D; Greminger P
    Radiologe; 2010 Jun; 50(6):548-52. PubMed ID: 20428995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
    Huang CK; Chen YS; Lee SS; Lin WR; Tsai HC; Lin HH; Wann SR; Chen JY; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combinatorial therapy for pneumonia in elderly people.
    Kanda A; Ebihara S; Yasuda H; Takashi O; Sasaki T; Sasaki H
    J Am Geriatr Soc; 2004 May; 52(5):846-7. PubMed ID: 15086678
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
    Pichardo C; Rodríguez-Martínez JM; Pachón-Ibañez ME; Conejo C; Ibáñez-Martínez J; Martínez-Martínez L; Pachón J; Pascual A
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3311-6. PubMed ID: 16048941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacies of ceftazidime and cefepime in rats with experimental pneumonia caused by extended-spectrum beta-lactamase-producing strain of Klebsiella pneumonia].
    Wang WF; Liu YN; She DY
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):390-4. PubMed ID: 17045021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Community-acquired pneumonia in a child].
    Korppi M
    Duodecim; 2010; 126(9):1065-70. PubMed ID: 20593629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefepime versus ceftazidime for treatment of pneumonia.
    Konstantinou K; Baddam K; Lanka A; Reddy K; Zervos M
    J Int Med Res; 2004; 32(1):84-93. PubMed ID: 14997712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
    Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
    Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of cefepime in the treatment of hospital-acquired pneumonia].
    Iakovlev SV; Romashov OM
    Antibiot Khimioter; 2005; 50(4):27-32. PubMed ID: 16392337
    [No Abstract]   [Full Text] [Related]  

  • 19. Fever, cough, and abdominal pain.
    Swischuk LE
    Pediatr Emerg Care; 2009 Oct; 25(10):696-7. PubMed ID: 19834423
    [No Abstract]   [Full Text] [Related]  

  • 20. Community-acquired pneumonia.
    Stone SP
    Lancet; 1998 Dec 19-26; 352(9145):2019. PubMed ID: 9872273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.